WHAT DO MULTIPLE INHALED ANTIBIOTICS TELL US ABOUT HOW INHALED ANTIBIOTICS WORK?

被引:0
作者
Waters, Valerie [1 ,2 ]
机构
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Toronto, ON, Canada
关键词
CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; TOBRAMYCIN; MUTATION; TRIAL;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
S11.3
引用
收藏
页码:162 / 163
页数:2
相关论文
共 10 条
[1]   Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and β-lactamase and alginate production [J].
Bagge, N ;
Schuster, M ;
Hentzer, M ;
Ciofu, O ;
Givskov, M ;
Greenberg, EP ;
Hoiby, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1175-1187
[2]   The Level of p38α Mitogen-Activated Protein Kinase Activation in Airway Epithelial Cells Determines the Onset of Innate Immune Responses to Planktonic and Biofilm Pseudomonas aeruginosa [J].
Beaudoin, Trevor ;
LaFayette, Shantelle ;
Roussel, Lucie ;
Berube, Julie ;
Desrosiers, Martin ;
Dao Nguyen ;
Rousseau, Simon .
JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (10) :1544-1555
[3]   A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis [J].
Hodson, ME ;
Gallagher, CG ;
Govan, JRW .
EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (03) :658-664
[4]   Aminoglycoside antibiotics induce bacterial biofilm formation [J].
Hoffman, LR ;
D'Argenio, DA ;
MacCoss, MJ ;
Zhang, ZY ;
Jones, RA ;
Miller, SI .
NATURE, 2005, 436 (7054) :1171-1175
[5]   Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial [J].
Kerem, Elton ;
Konstan, Michael W. ;
De Boeck, Kris ;
Accurso, Frank J. ;
Sermet-Gaudelus, Isabelle ;
Wilschanski, Michael ;
Elborn, J. Stuart ;
Melotti, Paola ;
Bronsveld, Inez ;
Fajac, Isabelle ;
Malfroot, Anne ;
Rosenbluth, Daniel B. ;
Walker, Patricia A. ;
McColley, Susanna A. ;
Knoop, Christiane ;
Quattrucci, Serena ;
Rietschel, Ernst ;
Zeitlin, Pamela L. ;
Barth, Jay ;
Elfring, Guy L. ;
Welch, Ellen M. ;
Branstrom, Arthur ;
Spiegel, Robert J. ;
Peltz, Stuart W. ;
Ajayi, Temitayo ;
Rowe, Steven M. .
LANCET RESPIRATORY MEDICINE, 2014, 2 (07) :539-547
[6]   Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial [J].
Konstan, Michael W. ;
Flume, Patrick A. ;
Kappler, Matthias ;
Chiron, Raphael ;
Higgins, Mark ;
Brockhaus, Florian ;
Zhang, Jie ;
Angyalosi, Gerhild ;
He, Ellie ;
Geller, David E. .
JOURNAL OF CYSTIC FIBROSIS, 2011, 10 (01) :54-61
[7]   A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation [J].
Ramsey, Bonnie W. ;
Davies, Jane ;
McElvaney, N. Gerard ;
Tullis, Elizabeth ;
Bell, Scott C. ;
Drevinek, Pavel ;
Griese, Matthias ;
McKone, Edward F. ;
Wainwright, Claire E. ;
Konstan, Michael W. ;
Moss, Richard ;
Ratjen, Felix ;
Sermet-Gaudelus, Isabelle ;
Rowe, Steven M. ;
Dong, Qunming ;
Rodriguez, Sally ;
Yen, Karl ;
Ordonez, Claudia ;
Elborn, J. Stuart .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (18) :1663-1672
[8]   Intermittent administration of inhaled tobramycin in patients with cystic fibrosis [J].
Ramsey, BW ;
Pepe, MS ;
Quan, JM ;
Otto, KL ;
Montgomery, AB ;
Williams-Warren, J ;
Vasiljev-K, M ;
Borowitz, D ;
Bowman, CM ;
Marshall, BC ;
Marshall, S ;
Smith, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (01) :23-30
[9]   Levofloxacin reduces inflammatory cytokine levels in human bronchial epithelia cells: implications for aerosol MP-376 (levofloxacin solution for inhalation) treatment of chronic pulmonary infections [J].
Tsivkovskii, Ruslan ;
Sabet, Mojgan ;
Tarazi, Ziad ;
Griffith, David C. ;
Lomovskaya, Olga ;
Dudley, Michael N. .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2011, 61 (02) :141-146
[10]   Applying clinical outcome variables to appropriate aerosolized antibiotics for the treatment of patients with cystic fibrosis [J].
VanDevanter, Donald R. ;
Ballmann, Manfred ;
Flume, Patrick A. .
RESPIRATORY MEDICINE, 2011, 105 :S18-S23